ALZYN is a development stage company pursuing a unique approach to retard the progress of Alzheimer's Disease. The science originated at the Florida State University's College of Medicine. The novel approach relies upon a well-researched combination of 4 well-characterized GRAS ingredients coupled with a proprietary transdermal delivery system that has proven capable of delivering the mal-abosrbed components to the brain.